Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
Exploring the Effect of Rumination-Focused Cognitive Behaviour Therapy on Depressive Symptoms in Patients With Schizophrenia: A Randomized Controlled Trial
This study has finished and is no longer accepting participants.
In Taipei
A 52-Week, Open-Label, Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia
This study ended early.
Multiple locations, including Phoenix
A 12-Month Randomized, Open-Label Study of Caregiver Psycho-education and Skills Training in Patients Recently Diagnosed With Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder and Receiving Paliperidone Palmitate or Oral Antipsychotic Treatment
This study has finished and is no longer accepting participants.
Multiple locations, including Bullhead CityFast Titration of Quetiapine Versus Conventional Titration in the Treatment of Schizophrenia/Schizoaffective Disorder: a Randomised, Parallel Group Open Trial
This study has finished and is no longer accepting participants.
In TaoyuanFast Titration Of Quetiapine Versus Currently Approved Titration: A Randomised, Multicentre, Parallel Group Open Trial In Schizophrenia And Schizoaffective Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including ArendalPhase I, Randomized, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AMG 579 in Healthy Adult Subjects and Patients With Stable Schizophrenia or Schizoaffective Disorder
This study ended early.
In GlendaleAn 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
This study has finished and is no longer accepting participants.
Location not clearly listedResearchers studied asenapine, tracking side effects to assess long-term safety and tolerability in young people with schizophrenia.
This study has finished and is no longer accepting participants.
Location not clearly listedA Multicenter, Randomized, Open-label, 2-arm, 2-period Crossover Trial to Investigate the Effects of Food on the Pharmacokinetics of a Single Dose of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In SagaThis study ended early.
In StrasbourgThis study assessed thinking abilities.
This study has finished and is no longer accepting participants.
In BeijingHigh Dose Lurasidone for Patients With Treatment Resistant Schizophrenia
This study has finished and is no longer accepting participants.
In ChicagoWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.